These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 37538794)

  • 1. Exploration of epithelial-mesenchymal transition-related lncRNA signature and drug sensitivity in breast cancer.
    Li C; Zheng L; Xu G; Yuan Q; Di Z; Yang Y; Dong X; Hou J; Wu G
    Front Endocrinol (Lausanne); 2023; 14():1154741. PubMed ID: 37538794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of the expression and prognostic significance of m
    Xu G; Li C; Di Z; Yang Y; Liang L; Yuan Q; Yang Q; Dong X; Xu S; Wu G
    Cancer Med; 2023 Mar; 12(6):7667-7681. PubMed ID: 36464884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of EMT-associated LncRNA Signature for Predicting the Prognosis of Patients with Endometrial Cancer.
    Shu W; Wang Z; Zhang W; Zhang J; Zhao R; Yu Z; Dong K; Wang H
    Comb Chem High Throughput Screen; 2023; 26(8):1488-1502. PubMed ID: 36200154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An epithelial-mesenchymal transition-related long noncoding RNA signature correlates with the prognosis and progression in patients with bladder cancer.
    Tong H; Li T; Gao S; Yin H; Cao H; He W
    Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33289830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Aging-Related Prognostic lncRNA Signature Correlated with Immune Cell Infiltration and Response to Immunotherapy in Breast Cancer.
    Liu Z; Ren C; Cai J; Yin B; Yuan J; Ding R; Ming W; Sun Y; Li Y
    Molecules; 2023 Apr; 28(8):. PubMed ID: 37110517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel epithelial-mesenchymal transition-related lncRNA signature predicts prognosis and immune status in endometrioid endometrial cancer.
    Jin Y; Qiu Y; Li Y; Jiang Z; Hu S; Dai H
    Medicine (Baltimore); 2023 Jun; 102(26):e34126. PubMed ID: 37390286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and Validation of EMT-Related lncRNA Prognostic Signature for Colorectal Cancer.
    Li D; Lin X; Chen B; Ma Z; Zeng Y; Wang H
    Front Genet; 2021; 12():723802. PubMed ID: 34659346
    [No Abstract]   [Full Text] [Related]  

  • 8. Identification of an Epithelial-Mesenchymal Transition-Related Long Non-coding RNA Prognostic Signature to Determine the Prognosis and Drug Treatment of Hepatocellular Carcinoma Patients.
    Huang S; Li D; Zhuang L; Zhang J; Wu J
    Front Med (Lausanne); 2022; 9():850343. PubMed ID: 35685422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An eight-lncRNA signature predicts survival of breast cancer patients: a comprehensive study based on weighted gene co-expression network analysis and competing endogenous RNA network.
    Sun M; Wu D; Zhou K; Li H; Gong X; Wei Q; Du M; Lei P; Zha J; Zhu H; Gu X; Huang D
    Breast Cancer Res Treat; 2019 May; 175(1):59-75. PubMed ID: 30715658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelial-mesenchymal transition-related lncRNAs associated with prognosis and immune cell infiltration in lung adenocarcinoma.
    Zhang Q; Wu X; Sun Y; Yang L; Wang Z; Yang Y; Zhao X; Zhang X
    Am J Transl Res; 2022; 14(10):7308-7323. PubMed ID: 36398231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oncogenic signaling pathway-related long non-coding RNAs for predicting prognosis and immunotherapy response in breast cancer.
    Li H; Liu H; Hao Q; Liu X; Yao Y; Cao M
    Front Immunol; 2022; 13():891175. PubMed ID: 35990668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of an epithelial-mesenchymal transition related long non-coding RNA (LncRNA) signature in Glioma.
    Tao C; Luo H; Chen L; Li J; Zhu X; Huang K
    Bioengineered; 2021 Dec; 12(1):4016-4031. PubMed ID: 34288803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction of an EMT-related lncRNA prognostic signature for lung adenocarcinoma and functional verification of its hub gene LINC01615.
    Shan Y; Xia T; Xie W; Wan W; Wu N; Yuan Z; Hu Q; Chen Z; Li C; Wu L; Wu W; Cai T; Xiang Y; Bai L; Li Y
    J Cancer Res Clin Oncol; 2023 Dec; 149(20):17781-17793. PubMed ID: 37934255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of prognostic melatonin-related lncRNA signature in tumor immune microenvironment and drug resistance for breast cancer.
    Gao SC; Wu MD; Zhang XX; Liu YF; Wang CL
    Asian J Surg; 2023 Sep; 46(9):3529-3541. PubMed ID: 37330302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mitochondrial function-related LncRNA signature predicts prognosis and immune microenvironment for breast cancer.
    Wang Y; Gao S; Xu Y; Tang Z; Liu S
    Sci Rep; 2023 Mar; 13(1):3918. PubMed ID: 36890266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of an EMT-related lncRNA signature and LINC01116 as an immune-related oncogene in hepatocellular carcinoma.
    Tao H; Zhang Y; Yuan T; Li J; Liu J; Xiong Y; Zhu J; Huang Z; Wang P; Liang H; Zhang E
    Aging (Albany NY); 2022 Feb; 14(3):1473-1491. PubMed ID: 35148283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel m7G-related lncRNA signature for predicting overall survival in patients with gastric cancer.
    Zhao B; Fang F; Liao Y; Chen Y; Wang F; Ma Y; Wei C; Zhao J; Ji H; Wang D; Tang D
    BMC Bioinformatics; 2023 Mar; 24(1):100. PubMed ID: 36935487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multi-omics analysis revealing a senescence-relevant lncRNAs signature for the assessment of response to immunotherapy for breast cancer.
    Yu Z; Zhu Y; Ji J
    Medicine (Baltimore); 2023 Jul; 102(28):e34287. PubMed ID: 37443486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A lymph node metastasis-related protein-coding genes combining with long noncoding RNA signature for breast cancer survival prediction.
    Sui Y; Ju C; Shao B
    J Cell Physiol; 2019 Nov; 234(11):20036-20045. PubMed ID: 30950057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel chemokine related LncRNA signature correlates with the prognosis, immune landscape, and therapeutic sensitivity of esophageal squamous cell cancer.
    Zhang Z; Wang J; Han W; Zhao L
    BMC Gastroenterol; 2023 Apr; 23(1):132. PubMed ID: 37081402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.